OR access to PPE good versus excellent | OR access to PPE basic versus excellent | OR access to PPE poor versus excellent | P trend | |
>14 days of symptoms | 1.26 (0.62–2.55) | 1.76 (0.86–3.61) | 2.39 (1.10–5.22) | 0.0044 |
Moderate to severe symptoms | 1.70 (0.90–3.20) | 1.63 (0.83–3.19) | 3.51 (1.70–7.26) | 0.0058 |
Specific COVID-19 symptoms: | ||||
Fatigue and muscle aches | 1.53 (0.79–2.93) | 2.07 (1.00–4.30) | 0.97 (0.46–2.08) | 0.86 |
Loss of taste or smell | 1.17 (0.66–2.09) | 1.74 (0.95–3.18) | 1.31 (0.67–2.58) | 0.46 |
Cough | 1.46 (0.85–2.51) | 1.59 (0.90–2.81) | 1.48 (0.78–2.79) | 0.36 |
Diarrhoea | 1.88 (0.94–3.73) | 2.04 (1.01–4.12) | 1.79 (0.82–3.89) | 0.28 |
Nausea or vomiting | 1.18 (0.53–2.64) | 2.53 (1.14–5.59) | 2.10 (0.87–5.07) | 0.029 |
Sore throat or headache | 2.40 (1.37–4.18) | 2.92 (1.62–5.27) | 2.15 (1.11–4.14) | 0.039 |
Fever or chills | 1.47 (0.85–2.56) | 1.49 (0.83–2.65) | 2.25 (1.16–4.39) | 0.049 |
Shortness of breath or difficulty breathing | 1.10 (0.60–2.03) | 1.46 (0.78–2.76) | 2.45 (1.22–4.93) | 0.021 |
Respiratory symptoms: abnormal chest X-ray, low oxygen saturation (SpO2) <93%) at rest, respiratory distress, respiratory rate ≥30 times/min, or acute lung injury | 1.48 (0.43–5.09) | 1.74 (0.48–6.30) | 3.33 (0.93–11.86) | 0.036 |
*Adjusted for age, gender, country, diabetes, pre-diabetes, coronary artery disease, overweight, asthma and high-risk exposure to an individual with COVID-19 outside of the workplace (n=568 total).
†Poor access to PPE was described as ‘little access to masks, face shields, gowns, and gloves’. Basic access was described as ‘access to at least one daily mask, face shield, gown, and gloves’. Good access to PPE was described as ‘I had access to a change of mask, gown, and gloves if soiled as well as a face shield’. Excellent access to PPE was described as ‘I had access to a fresh mask, gown, and gloves every time that I entered a new patient room as well as a face shield’.